showed a trendp = 0.19
Further analysis of the PI3K/PTEN/Akt pathway in the cyclophosphamide-treated samples showed a trend toward a decline in Akt-1 (p = 0.19) and no significant change in the expressions of Foxo3a (p = 0.8) and rpS6 (p = 0.36) (Fig. 3 D–F).